Although two thirds of the 120 million people infected with lymph-dwelling filarial parasites have subclinical infections, ∼40 million have lymphedema and/or other pathologic manifestations including hydroceles (and other forms of urogenital disease), episodic adenolymphangitis, lymphedema, and (in its most severe form) elephantiasis. Adult filarial worms reside in the lymphatics and lymph nodes and induce lymphatic dilatation. Progressive lymphatic damage and pathology results primarily from the host inflammatory response to the parasites but also perhaps from the host inflammatory response to the parasite's Wolbachia endosymbiont and as a consequence of superimposed bacterial or fungal infections. This review will attempt to shed light on disease pathogenesis in lymphatic filariasis.
Get full access to this article
View all access options for this article.
References
1.
FenwickA. The global burden of neglected tropical diseases. Public Health., Mar2012; 126:233–236.
2.
Global programme to eliminate lymphatic filariasis. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations=Weekly epidemiological record/Health Section of the Secretariat of the League of Nations. Oct19, 2007; 82:361–380.
3.
Lymphatic filariasis:. the disease and its control. Fifth report of the WHO Expert Committee on Filariasis. World Health Organ Tech Rep Ser., 1992; 821:1–71.
4.
FreedmanDO, de Almeida FilhoPJ, BeshS, Maia e SilvaMC, BragaC, MacielA. Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis. J Infect Dis., Oct1994; 170:927–933.
5.
FreedmanDO, de Almeido FilhoPJ, BeshSet al.Abnormal lymphatic function in presymptomatic bancroftian filariasis. J Infect Dis., Apr1995; 171,4:997–1001.
6.
NoroesJ, AddissD, AmaralF, CoutinhoA, MedeirosZ, DreyerG. Occurrence of living adult Wuchereria bancrofti in the scrotal area of men with microfilaraemia. Trans R Soc Trop Med Hyg., Jan-Feb1996; 90:55–56.
7.
NoroesJ, AddissD, SantosA, MedeirosZ, CoutinhoA, DreyerG. Ultrasonographic evidence of abnormal lymphatic vessels in young men with adult Wuchereria bancrofti infection in the scrotal area. J Urol., Aug1996; 156:409–412.
8.
PartonoF. The spectrum of disease in lymphatic filariasis. Ciba Found Symp., 1987; 127:15–31.
9.
PaniSP, SrividyaA. Clinical manifestations of bancroftian filariasis with special reference to lymphoedema grading. Indian J Med Res., Sep1995; 102:114–118.
10.
DreyerG, MedeirosZ, NettoMJ, LealNC, de CastroLG, PiessensWF. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans R Soc Trop Med Hyg., Jul-Aug1999; 93:413–417.
11.
DreyerG, NoroesJ, Figueredo-SilvaJ, PiessensWF. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol Today, Dec2000; 16:544–548.
12.
Figueredo-SilvaJ, NoroesJ, CedenhoA, DreyerG. The histopathology of bancroftian filariasis revisited: the role of the adult worm in the lymphatic-vessel disease. Ann Trop Med Parasitol., Sep2002; 96:531–541.
13.
OlszewskiWL, JamalS, ManokaranG, LukomskaB, KubickaU. Skin changes in filarial and non-filarial lymphoedema of the lower extremities. Trop Med Parasitol., Mar1993; 44:40–44.
14.
DreyerG, NoroesJ, AddissD, SantosA, MedeirosZ, Figueredo-SilvaJ. Bancroftian filariasis in a paediatric population: an ultrasonographic study. Trans R Soc Trop Med Hyg., Nov-Dec1999; 93:633–636.
15.
AmaralF, DreyerG, Figueredo-SilvaJet al.Live adult worms detected by ultrasonography in human Bancroftian filariasis. Am J Trop Med Hyg., Jun1994; 50:753–757.
16.
DreyerG, AmaralF, NoroesJ, MedeirosZ. Ultrasonographic evidence for stability of adult worm location in bancroftian filariasis. Trans R Soc Trop Med Hyg., Sep-Oct1994; 88:558.
17.
ConnorDH, PalmieriJR, GibsonDW. Pathogenesis of lymphatic filariasis in man. Z Parasitenkd., 1986; 72:13–28.
18.
von LichtenbergF. The Wellcome Trust lecture. Inflammatory responses to filarial connective tissue parasites. Parasitology., 1987; 94,Suppl:S101–122.
19.
OlszewskiWL, JamalS, ManokaranGet al.Bacteriologic studies of skin, tissue fluid, lymph, and lymph nodes in patients with filarial lymphedema. Am J Trop Med Hyg., Jul1997; 57:7–15.
20.
ShenoyRK, KumaraswamiV, SumaTK, RajanK, RadhakuttyammaG. A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis. Ann Trop Med Parasitol., Jun1999; 93:367–377.
21.
VickeryAC, AlbertineKH, NayarJK, KwaBH. Histopathology of Brugia malayi-infected nude mice after immune-reconstitution. Acta Trop., Apr1991; 49:45–55.
22.
VincentAL, VickeryAC, LotzMJ, DesaiU. The lymphatic pathology of Brugia pahangi in nude (athymic) and thymic mice C3H/HeN. J Parasitol., Feb1984; 70:48–56.
23.
NelsonFK, GreinerDL, ShultzLD, RajanTV. The immunodeficient scid mouse as a model for human lymphatic filariasis. J Exp Med., Mar1, 1991; 173:659–663.
24.
LalRB, DhawanRR, RamzyRM, FarrisRM, GadAA. C-reactive protein in patients with lymphatic filariasis: increased expression on lymphocytes in chronic lymphatic obstruction. J Clin Immunol., Jan1991; 11:46–53.
25.
DasBK, SahooPK, RavindranB. A role for tumour necrosis factor-alpha in acute lymphatic filariasis. Parasite Immunol., Aug1996; 18:421–424.
26.
SatapathyAK, SartonoE, SahooPKet al.Human bancroftian filariasis: immunological markers of morbidity and infection. Microbes Infect., Aug2006; 8:2414–2423.
27.
el-SharkawyIM, HaseebAN, SalehWA. Serum levels of endothelin-1 (ET-1), interleukin-2 (IL-2) and amino-terminal propeptide type III procollagen (PIII NP) in patients with acute and chronic filariasis. J Egypt Soc Parasitol., Apr2001; 31:169–176.
28.
BabuS, BlauveltCP, KumaraswamiV, NutmanTB. Chemokine receptors of T cells and of B cells in lymphatic filarial infection: a role for CCR9 in pathogenesis. J Infect Dis., Mar15, 2005; 191:1018-1–026.
29.
OlszewskiWL, JamalS, LukomskaB, ManokaranG, GrzelakI. Immune proteins in peripheral tissue fluid-lymph in patients with filarial lymphedema of the lower limbs. Lymphology., Dec1992; 25:166–171.
BennuruS, NutmanTB. Lymphatics in human lymphatic filariasis: in vitro models of parasite-induced lymphatic remodeling. Lymphat Res Biol., Dec2009; 7:215–219.
32.
RaoUR, ZometaCS, VickeryAC, KwaBH, NayarJK, SuttonET. Effect of Brugia malayi on the growth and proliferation of endothelial cells in vitro. J Parasitol., Aug1996; 82:550–556.
33.
BennuruS, NutmanTB. Lymphangiogenesis and lymphatic remodeling induced by filarial parasites: implications for pathogenesis. PLoS Pathog., Dec2009; 5:e1000688.
DebrahAY, MandS, SpechtSet al.Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog., Sep2006; 2:e92.
36.
BennuruS, MaldarelliG, KumaraswamiV, KlionAD, NutmanTB. Elevated levels of plasma angiogenic factors are associated with human lymphatic filarial infections. Am J Trop Med Hyg., Oct2010; 83:884–890.
37.
McLarenDJ, WormsMJ, LaurenceBR, SimpsonMG. Micro-organisms in filarial larvae (Nematoda)Trans R Soc Trop Med Hyg., 1975; 69:509–514.
38.
TaylorMJ, CrossHF, BiloK. Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria. J Exp Med., Apr17, 2000; 191:1429–1436.
39.
EsterreP, PlichartC, Huin-BlondeyMO, NguyenLN. Soluble cellular adhesion molecules, selectins, VEGF and endothelin-1 in patients with Wuchereria bancrofti infection and association with clinical status. Parasite Immunol., Jan-Feb2005; 27:9–16.
40.
VenugopalPG, NutmanTB, SemnaniRT. Activation and regulation of Toll-Like Receptors (TLRs) by helminth parasites. Immunol Res., 2009; 43:252–263.
41.
BabuS, BhatSQ, Pavan KumarNet al.Filarial lymphedema is characterized by antigen-specific Th1 and th17 proinflammatory responses and a lack of regulatory T cells. PLoS Negl Trop Dis., 2009; 3:e420.
42.
BrenchleyJM, DouekDC. Microbial translocation across the GI tract. Annu Rev Immunol., 2012; 30:149–173.
43.
AnuradhaR. Circulating microbial products, acute phase proteins as markers of pathogenesis in lymphatic filarial disease. PLoS Pathog., 2012.
44.
AnuradhaR. Altered circulating levels of matrix metallproteinases, inhibitors associated with elevated Type 2 cytokines in lymphatic filarial disease. PLoS Negl Trop Dis., 2012.
45.
FreedmanDO, HornTD, Maia e SilvaCM, BragaC, MacielA. Predominant CD8+ infiltrate in limb biopsies of individuals with filarial lymphedema and elephantiasis. Am J Trop Med Hyg., Dec1995; 53:633–638.
46.
FreedmanDO, NutmanTB, OttesenEA. Protective immunity in bancroftian filariasis. Selective recognition of a 43-kD larval stage antigen by infection-free individuals in an endemic area. J Clin Invest., Jan1989; 83:14–22.
47.
FreedmanDO, Parker-CookS, Maia e SilvaMC, BragaC, MacielA. Very late antigen-4/vascular cell adhesion molecule-1 (VLA-4/VCAM-1) pathway is involved in the transendothelial migration of lymphocytes in bancroftian filariasis. J Immunol., Apr15, 1996; 156:2901–2908.
48.
FreedmanDO, PlierDA, de AlmeidaAet al.Biased TCR repertoire in infiltrating lesional T cells in human Bancroftian filariasis. J Immunol., Feb1, 1999; 162:1756–1764.
49.
NutmanTB, KumaraswamiV, OttesenEA. Parasite-specific anergy in human filariasis. Insights after analysis of parasite antigen-driven lymphokine production. J Clin Invest., May1987; 79:1516–1523.
50.
PiessensWF, PartonoF, HoffmanSLet al.Antigen-specific suppressor T lymphocytes in human lymphatic filariasis. N Engl J Med., Jul15, 1982; 307:144–148.
51.
KingCL, MahantyS, KumaraswamiVet al.Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest., Oct1993; 92:1667–1673.
52.
de AlmeidaAB, SilvaMC, BragaC, FreedmanDO. Differences in the frequency of cytokine-producing cells in antigenemic and nonantigenemic individuals with bancroftian filariasis. Infect Immun., Apr1998; 66:1377–1383.
53.
BabuS, NutmanTB. Immunopathogenesis of lymphatic filarial disease. Seminars in immunopathology., Nov2012; 34:847–861.
54.
ChanSH, DissanayakeS, MakJWet al.HLA and filariasis in Sri Lankans and Indians. Southeast Asian J Trop Med Public Health., Sep1984; 15:281–286.
55.
YazdanbakhshM, SartonoE, KruizeYCet al.HLA and elephantiasis in lymphatic filariasis. Hum Immunol., Sep1995; 44:58–61.
56.
ChoiEH, ZimmermanPA, FosterCBet al.Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun., Aug2001; 2:248–253.
57.
CuencoKT, HalloranME, LammiePJ. Assessment of families for excess risk of lymphedema of the leg in a lymphatic filariasis-endemic area. Am J Trop Med Hyg., Feb2004; 70:185–190.
58.
CuencoKT, HalloranME, Louis-CharlesJ, LammiePJ. A family study of lymphedema of the leg in a lymphatic filariasis-endemic area. Am J Trop Med Hyg., Feb2004; 70:180–184.
59.
DebrahAY, MandS, ToliatMRet al.Plasma vascular endothelial growth Factor-A (VEGF-A) and VEGF-A gene polymorphism are associated with hydrocele development in lymphatic filariasis. Am J Trop Med Hyg., Oct2007; 77:601–608.
60.
PandaAK, SahooPK, KerkettaAS, KarSK, RavindranB, SatapathyAK. Human lymphatic filariasis: genetic polymorphism of endothelin-1 and tumor necrosis factor receptor II correlates with development of chronic disease. J Infect Dis., Jul15, 2011; 204:315–322.
